Literature DB >> 25859600

[Novel achievements in development and application of GPCR-peptides].

A O Shpakov, K V Derkach.   

Abstract

One of the approaches to creating the regulators of G-protein-coupled receptors (GPCR) is the development of peptides that structurally correspond to the functionally important regions of the intracellular extracellular loops of the receptors. GPCR-peptides can selectively regulate the functional activity of homologous receptor and affect the hormonal signal transduction via the receptor. Among the peptides corresponding to the intracellular regions of GPCR, their derivatives modified with hydrophobic radicals exhibit the highest activity and selectivity of action in vitro and in vivo. Ample evidence demonstrates that lipophilic GPCR-peptides may be used to treat diseases and various abnormalities that depend on the functional activity of receptors homologous to them. In turn, the peptides corresponding to the extracellular regions of GPCR can be used as functional probes for studying the specific interaction between the receptors and their ligands, as well as for studying the etiology and pathogenesis of autoimmune diseases caused by the production of antibodies to GPCR antigenic determinants that are localized in the receptor extracellular loops. The present review focuses on the recent achievements in development and application of GPCR-peptides and on the prospects for their further use in medicine and fundamental biology.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25859600     DOI: 10.1134/s0022093015010020

Source DB:  PubMed          Journal:  Zh Evol Biokhim Fiziol        ISSN: 0044-4529


  48 in total

1.  beta-arrestin-dependent desensitization of luteinizing hormone/choriogonadotropin receptor is prevented by a synthetic peptide corresponding to the third intracellular loop of the receptor.

Authors:  S Mukherjee; K Palczewski; V V Gurevich; M Hunzicker-Dunn
Journal:  J Biol Chem       Date:  1999-05-07       Impact factor: 5.157

2.  Role of anti-β1 adrenergic antibodies from patients with periodontitis in cardiac dysfunction.

Authors:  Marcela Segovia; Sabrina Ganzinelli; Silvia Reina; Enri Borda; Leonor Sterin-Borda
Journal:  J Oral Pathol Med       Date:  2011-09-30       Impact factor: 4.253

3.  Targeting protease activated receptor-1 with P1pal-12 limits bleomycin-induced pulmonary fibrosis.

Authors:  Cong Lin; Janwillem Duitman; Joost Daalhuisen; Marieke Ten Brink; Jan von der Thüsen; Tom van der Poll; Keren Borensztajn; C Arnold Spek
Journal:  Thorax       Date:  2013-09-12       Impact factor: 9.139

Review 4.  Transmembrane signaling by G protein-coupled receptors.

Authors:  Louis M Luttrell
Journal:  Methods Mol Biol       Date:  2006

5.  Antibodies raised against different extracellular loops of the melanocortin-3 receptor affect energy balance and autonomic function in rats.

Authors:  Jean-Christophe Peter; Géraldine Zipfel; Anne-Catherine Lecourt; Akkiz Bekel; Karl G Hofbauer
Journal:  J Recept Signal Transduct Res       Date:  2010-12       Impact factor: 2.092

6.  Insider access: pepducin symposium explores a new approach to GPCR modulation.

Authors:  Jacquelyn Miller; Anika Agarwal; Lakshmi A Devi; Kellen Fontanini; James A Hamilton; Jean-Philippe Pin; Denis C Shields; C Arnold Spek; Thomas P Sakmar; Athan Kuliopulos; Stephen W Hunt
Journal:  Ann N Y Acad Sci       Date:  2009-11       Impact factor: 5.691

Review 7.  [Peptides derived from the extracellular loop of receptors: structure, mechanisms of action and application in physiology and medicine].

Authors:  A O Shpakov
Journal:  Ross Fiziol Zh Im I M Sechenova       Date:  2011-05

8.  Inactivation and intracellular retention of the human I183N mutated melanocortin 3 receptor associated with obesity.

Authors:  Mohamed Rached; Anna Buronfosse; Martine Begeot; Armelle Penhoat
Journal:  Biochim Biophys Acta       Date:  2004-08-04

9.  Pepducin-based intervention of thrombin-receptor signaling and systemic platelet activation.

Authors:  Lidija Covic; Meghna Misra; Jehangir Badar; Christopher Singh; Athan Kuliopulos
Journal:  Nat Med       Date:  2002-09-23       Impact factor: 53.440

Review 10.  The functional state of hormone-sensitive adenylyl cyclase signaling system in diabetes mellitus.

Authors:  Alexander O Shpakov; Kira V Derkach
Journal:  J Signal Transduct       Date:  2013-09-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.